Elevai Labs, Inc. - Common Stock
(NQ:
ELAB
)
0.2664
-0.0019 (-0.71%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
411,965
Open
0.2656
Bid (Size)
0.2450 (3)
Ask (Size)
0.2499 (8)
Prev. Close
0.2683
Today's Range
0.2541 - 0.2720
52wk Range
0.2175 - 4.244
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™
August 28, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum
August 26, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Performance
YTD
-85.90%
-85.90%
1 Month
-32.06%
-32.06%
3 Month
-60.77%
-60.77%
6 Month
-64.62%
-64.62%
1 Year
-92.16%
-92.16%
More News
Read More
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
August 26, 2024
Via
Benzinga
ELAB Stock Earnings: Elevai Labs Reported Results for Q2 2024
August 14, 2024
Via
InvestorPlace
ELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024
May 15, 2024
Via
InvestorPlace
Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 23, 2024
Via
Benzinga
Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications
August 19, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
July 30, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 25, 2024
Via
Benzinga
Top 4 Risk Off Stocks You'll Regret Missing In July
July 16, 2024
Via
Benzinga
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
June 28, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
June 26, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
June 14, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm
May 29, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
May 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries
May 17, 2024
Via
News Direct
Elevai Labs Inc. Reports First Quarter 2024 Financial Results
May 15, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
May 02, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
May 01, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
May 01, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
April 29, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
April 22, 2024
From
Elevai Labs Inc.
Via
GlobeNewswire
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.